v3.26.1
Stock Options - Schedule of Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Stock Options [Line Items]      
Number of Shares, Ending Balance 11,496,525 14,133,650 14,320,000
Weighted - Average Exercise Price, Ending Balance $ 0.8 $ 0.9 $ 0.9
Weighted - Average Remaining Contractual Term, Ending Balance 1 year 10 months 24 days 9 months 18 days 1 year 6 months
Aggregate Intrinsic Value, Ending Balance [1] $ 93 $ 2,232 $ 8,416
Number of Shares, Exercisable (in Shares) 11,496,525    
Weighted Average Exercise Price, Exercisable $ 0.8    
Weighted Average Remaining Contractual Term, Exercisable 1 year 10 months 24 days    
Aggregate Intrinsic Value, Exercisable (in Dollars) [1] $ 93    
Number of Shares, Exercisable and expected to vest thereafter 11,496,525    
Weighted - Average Exercise Price, Exercisable and expected to vest thereafter $ 0.8    
Weighted - Average Remaining Contractual Term, Exercisable and expected to vest thereafter 1 year 10 months 24 days    
Aggregate Intrinsic Value, Exercisable and expected to vest thereafter [1] $ 93    
Number of Shares, Granted   2,315,000 611,150
Weighted - Average Exercise Price, Granted   $ 0.37 $ 1.03
Weighted - Average Remaining Contractual Term, Granted   4 years 1 month 6 days 1 year 6 months
Aggregate Intrinsic Value, Granted [1]  
Number of Shares, Exercised  
Weighted - Average Exercise Price, Exercised  
Aggregate Intrinsic Value, Exercised [1]  
Number of Shares, Expired/Cancelled   (4,952,125) (797,500)
Weighted - Average Exercise Price, Expired/Cancelled   $ 0.88 $ 0.94
Aggregate Intrinsic Value, Expired/Cancelled [1]  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.33 and $0.94 for Company’s common stock on December 31, 2025 and 2024.